Feasibility, Acceptability, and Preliminary Clinical Impact of a Computer-Assisted Transdiagnostic CBT Intervention for Veterans with Co-Occurring Anxiety and Substance Use Disorders.
Alan Z Sheinfil, Michael A Cucciare, Kate Wolitzky-Taylor, Jeffrey A Cully, Jan A Lindsay, Anthony H Ecker
{"title":"Feasibility, Acceptability, and Preliminary Clinical Impact of a Computer-Assisted Transdiagnostic CBT Intervention for Veterans with Co-Occurring Anxiety and Substance Use Disorders.","authors":"Alan Z Sheinfil, Michael A Cucciare, Kate Wolitzky-Taylor, Jeffrey A Cully, Jan A Lindsay, Anthony H Ecker","doi":"10.1080/15504263.2025.2559174","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study examined feasibility, acceptability, and preliminary clinical impact of Veterans Affairs Coordinated Anxiety Learning and Management- Substance (VA CALM-S), a computer-assisted, transdiagnostic cognitive behavioral intervention for co-occurring anxiety and substance use disorders (SUDs) among veterans.</p><p><strong>Methods: </strong>Veterans with co-occurring anxiety and SUDs were randomized to receive VA CALM-S (n = 14) or usual care (n = 12). Acceptability and feasibility were assessed via treatment completion rates and qualitative feedback. Changes in self-reported anxiety symptoms, substance use, and substance-related consequences were assessed at posttreatment.</p><p><strong>Results: </strong>Eighty-five percent of participants completed all VA CALM-S modules. Qualitative feedback indicated the intervention was well-received and helpful. Moderate-to-large effect sizes were observed for VA CALM-S in reducing anxiety symptoms (<i>d</i> = 0.64), substance use (<i>d</i> = 0.69), and substance-related consequences (<i>d</i> = 0.34). Relatively smaller effect sizes were observed for the usual care condition in anxiety symptoms (<i>d</i> = 0.24), substance use (<i>d</i> = 0.12), and substance-related consequences (<i>d</i> = -0.46).</p><p><strong>Conclusions: </strong>Findings support the feasibility and acceptability of VA CALM-S for veterans with co-occurring anxiety and SUDs.</p>","PeriodicalId":46571,"journal":{"name":"Journal of Dual Diagnosis","volume":" ","pages":"1-11"},"PeriodicalIF":2.6000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Dual Diagnosis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/15504263.2025.2559174","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: This study examined feasibility, acceptability, and preliminary clinical impact of Veterans Affairs Coordinated Anxiety Learning and Management- Substance (VA CALM-S), a computer-assisted, transdiagnostic cognitive behavioral intervention for co-occurring anxiety and substance use disorders (SUDs) among veterans.
Methods: Veterans with co-occurring anxiety and SUDs were randomized to receive VA CALM-S (n = 14) or usual care (n = 12). Acceptability and feasibility were assessed via treatment completion rates and qualitative feedback. Changes in self-reported anxiety symptoms, substance use, and substance-related consequences were assessed at posttreatment.
Results: Eighty-five percent of participants completed all VA CALM-S modules. Qualitative feedback indicated the intervention was well-received and helpful. Moderate-to-large effect sizes were observed for VA CALM-S in reducing anxiety symptoms (d = 0.64), substance use (d = 0.69), and substance-related consequences (d = 0.34). Relatively smaller effect sizes were observed for the usual care condition in anxiety symptoms (d = 0.24), substance use (d = 0.12), and substance-related consequences (d = -0.46).
Conclusions: Findings support the feasibility and acceptability of VA CALM-S for veterans with co-occurring anxiety and SUDs.
期刊介绍:
Journal of Dual Diagnosis is a quarterly, international publication that focuses on the full spectrum of complexities regarding dual diagnosis. The co-occurrence of mental health and substance use disorders, or “dual diagnosis,” is one of the quintessential issues in behavioral health. Why do such high rates of co-occurrence exist? What does it tell us about risk profiles? How do these linked disorders affect people, their families, and the communities in which they live? What are the natural paths to recovery? What specific treatments are most helpful and how can new ones be developed? How can we enhance the implementation of evidence-based practices at clinical, administrative, and policy levels? How can we help clients to learn active recovery skills and adopt needed supports, clinicians to master new interventions, programs to implement effective services, and communities to foster healthy adjustment? The Journal addresses each of these perplexing challenges.